Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (1025)	6/16/2006 5:39:30 PM
From: Mike McFarland	Read Replies (3) \| Respond to of 1336

are you up for listkeeping: Drug Repositioning? Auriga, Gene Logic, Gentris, KineMed, Neurocure, Penwest, Melior, Sosei, TAP, Vicus Distinguished Speakers cbinet.com That is a start, maybe. I do not remember seeing a Wendy Warr list. I like Gene Logic too. Maybe they will spin down some of the least profitable stuff (genomics?) and focus on the "DR". Remind me to listen to the next call, there ought to be one in July at next earnings, right? I don't trust Yahoo at all, but this guy breaks it down and is right: The screaming message is they will live or die by the DR. messages.yahoo.com Tartaglia is the fellow you want to pair with your various google searches. <I can't even remember the name of the company that GLGC bought that got me into it!> Someday I will forget entirely that I owned Axys too--not that I owned it or dpii continiously. But it is funny how they move around and reposition themselves <g> Have a good weekend everybody. I just realized that today is Friday, ha!